Robert Marcus
Stock Analyst at JP Morgan
(1.43)
# 2,495
Out of 4,433 analysts
8
Total ratings
55.56%
Success rate
6.39%
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $27.54 | - | 2 | Dec 17, 2021 | |
| BDX Becton, Dickinson and Company | Downgrades: Neutral | n/a | $236.30 | - | 1 | Aug 6, 2021 | |
| GKOS Glaukos | Downgrades: Underweight | n/a | $109.79 | - | 1 | Oct 8, 2020 | |
| TMDX TransMedics Group | Downgrades: Neutral | n/a | $137.98 | - | 1 | Oct 8, 2020 | |
| AFIB Acutus Medical | Initiates: Overweight | n/a | $0.06 | - | 1 | Aug 31, 2020 | |
| ATRC AtriCure | Maintains: Overweight | n/a | $23.14 | - | 1 | Apr 28, 2020 | |
| NVRO Nevro | Maintains: Neutral | n/a | $11.40 | - | 1 | Apr 2, 2020 |
Integra LifeSciences Holdings
Dec 17, 2021
Upgrades: Neutral
Price Target: n/a
Current: $27.54
Upside: -
Becton, Dickinson and Company
Aug 6, 2021
Downgrades: Neutral
Price Target: n/a
Current: $236.30
Upside: -
Glaukos
Oct 8, 2020
Downgrades: Underweight
Price Target: n/a
Current: $109.79
Upside: -
TransMedics Group
Oct 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $137.98
Upside: -
Acutus Medical
Aug 31, 2020
Initiates: Overweight
Price Target: n/a
Current: $0.06
Upside: -
AtriCure
Apr 28, 2020
Maintains: Overweight
Price Target: n/a
Current: $23.14
Upside: -
Nevro
Apr 2, 2020
Maintains: Neutral
Price Target: n/a
Current: $11.40
Upside: -